Por favor, use este identificador para citar o enlazar este ítem: https://hdl.handle.net/10495/38829
Registro completo de metadatos
Campo DC Valor Lengua/Idioma
dc.contributor.authorCeballos Rueda, Javier Mauricio-
dc.contributor.authorAmariles Muñoz, Pedro-
dc.contributor.authorSalazar Ospina, Andrea-
dc.contributor.authorSabater Hernández, Daniel-
dc.date.accessioned2024-03-27T20:09:25Z-
dc.date.available2024-03-27T20:09:25Z-
dc.date.issued2020-
dc.identifier.citationCeballos, M., Salazar-Ospina, A., Sabater-Hernández, D. et al. Evaluation of the effects of a drug with fiscalized substance dispensation, health education, and pharmacovigilance continuing education program in Colombia drugstores and drugstores/pharmacies: study protocol of a multicenter, cluster-randomized controlled trial. Trials 21, 545 (2020). https://doi.org/10.1186/s13063-020-04481-1spa
dc.identifier.issn1745-6215-
dc.identifier.urihttps://hdl.handle.net/10495/38829-
dc.description.abstractABSTRACT: Background: Health disorders, due to the use of drugs with fiscalized substances, including controlled substances, have become a common problem in Colombia. Multiple reasons can help explain this problem, including selfmedication, since access to these drugs may be easier. Also, there is a lack of knowledge that these drugs are safer than illicit drugs. The use of these drugs without a valid medical prescription and follow-up can have negative consequences such as drug abuse, addiction, and overdose, and eventually, have negative health consequences. Pharmacy staff is essential to both assure the correct drug use and minimize prescription errors to help outpatients have better management of their pharmacotherapy. For this reason, it is necessary to increase key competencies like knowledge, skills, and attitudes in the pharmacy staff of ambulatory (outpatients) pharmacies. Methods: This study is a prospective, cluster-randomized, parallel-group, multicenter trial of drugstores and drugstores/pharmacies (ambulatory pharmacies). The study is designed to determine the effectiveness of a drug with fiscalized substance dispensation, health education, and pharmacovigilance continuing education program in drugstores and drugstores/pharmacies. Pharmacy staff will be randomly selected and assigned to one of the study groups (intervention or control). The intervention group will receive a continuing education program for over 12 months. The control group will receive only general information about the correct use of complex dosage forms. The primary objective is to evaluate the effectiveness of a continuing education program to improve pharmacy staff competencies (knowledge, skills, and attitudes) to improve the ambulatory (outpatient) pharmacy services: dispensation, health education, and pharmacovigilance of drugs with fiscalized substances. The secondary outcomes include (a) processes associated with the management of drugs with fiscalized substances in drugstores and drugstores/pharmacies, including regulation compliance; (b) degree of implementation of ambulatory (outpatient) pharmacy services targeting these drugs in drugstores and drugstores/pharmacies; (c) patient satisfaction with such services; and (d) pharmacy staff satisfaction with the continuing education program. Discussion: This clinical trial will establish whether providing a continuing education program for the adequate utilization of drugs with fiscalized substances improves pharmacy staff competencies regarding these drugs. Trial registration: ClinicalTrials.gov NCT03388567. Registered on 28 November 2017. First drugstore or drugstore/pharmacy randomized on December 1, 2018. Protocol version: 0017102017MCspa
dc.format.extent14 páginasspa
dc.format.mimetypeapplication/pdfspa
dc.language.isoengspa
dc.publisherBMC (BioMed Central)spa
dc.type.hasversioninfo:eu-repo/semantics/publishedVersionspa
dc.rightsinfo:eu-repo/semantics/openAccessspa
dc.rights.urihttp://creativecommons.org/licenses/by/2.5/co/*
dc.subject.meshCompetencia Clínica-
dc.subject.meshClinical Competence-
dc.subject.meshColombia-
dc.subject.meshEducación Continua en Farmacia - métodos-
dc.subject.meshEducation, Pharmacy, Continuing - methods-
dc.subject.meshEducación en Salud - métodos-
dc.subject.meshHealth Education - methods-
dc.subject.meshConocimientos, Actitudes y Práctica en Salud-
dc.subject.meshHealth Knowledge, Attitudes, Practice-
dc.subject.meshHumanos-
dc.subject.meshHumans-
dc.subject.meshEstudios Multicéntricos como Asunto-
dc.subject.meshMulticenter Studies as Topic-
dc.subject.meshFarmacias-
dc.subject.meshPharmacies-
dc.subject.meshFarmacéuticos - organización & administración-
dc.subject.meshPharmacists - organization & administration-
dc.subject.meshFarmacovigilancia-
dc.subject.meshPharmacovigilance-
dc.subject.meshEstudios Prospectivos-
dc.subject.meshProspective Studies-
dc.subject.meshEnsayos Clínicos Controlados Aleatorios como Asunto-
dc.subject.meshRandomized Controlled Trials as Topic-
dc.titleEvaluation of the effects of a drug with fiscalized substance dispensation, health education, and pharmacovigilance continuing education program in Colombia drugstores and drugstores/pharmacies: study protocol of a multicenter, cluster-randomized controlled trialspa
dc.typeinfo:eu-repo/semantics/articlespa
dc.publisher.groupGrupo de Investigación de Tecnología en Regencia de Farmaciaspa
dc.publisher.groupPromoción y Prevención Farmacéuticaspa
dc.identifier.doi10.1186/s13063-020-04481-1-
oaire.versionhttp://purl.org/coar/version/c_970fb48d4fbd8a85spa
dc.rights.accessrightshttp://purl.org/coar/access_right/c_abf2spa
oaire.citationtitleTrialsspa
oaire.citationstartpage1spa
oaire.citationendpage14spa
oaire.citationvolume21spa
oaire.citationissue545spa
dc.rights.creativecommonshttps://creativecommons.org/licenses/by/4.0/spa
oaire.fundernameUniversidad de Antioquiaspa
oaire.fundernameLaboratorios Laproff S.Aspa
dc.publisher.placeLondres, Inglaterraspa
dc.type.coarhttp://purl.org/coar/resource_type/c_2df8fbb1spa
dc.type.redcolhttps://purl.org/redcol/resource_type/ARTspa
dc.type.localArtículo de investigaciónspa
dc.description.researchgroupidCOL0135121spa
dc.description.researchgroupidCOL0074661spa
oaire.awardnumber2018–2019spa
dc.subject.meshurihttps://id.nlm.nih.gov/mesh/D002983-
dc.subject.meshurihttps://id.nlm.nih.gov/mesh/D003105-
dc.subject.meshurihttps://id.nlm.nih.gov/mesh/D004513-
dc.subject.meshurihttps://id.nlm.nih.gov/mesh/D006266-
dc.subject.meshurihttps://id.nlm.nih.gov/mesh/D007722-
dc.subject.meshurihttps://id.nlm.nih.gov/mesh/D006801-
dc.subject.meshurihttps://id.nlm.nih.gov/mesh/D015337-
dc.subject.meshurihttps://id.nlm.nih.gov/mesh/D010594-
dc.subject.meshurihttps://id.nlm.nih.gov/mesh/D010595-
dc.subject.meshurihttps://id.nlm.nih.gov/mesh/D060735-
dc.subject.meshurihttps://id.nlm.nih.gov/mesh/D011446-
dc.subject.meshurihttps://id.nlm.nih.gov/mesh/D016032-
dc.relation.ispartofjournalabbrevTrials.spa
oaire.funderidentifier.rorRoR:03bp5hc83-
Aparece en las colecciones: Artículos de Revista en Farmacéutica y Alimentarias

Ficheros en este ítem:
Fichero Descripción Tamaño Formato  
CeballosJavier_2020_Evaluation_Effects_Drug_Fiscalized.pdfArtículo de investigación1.4 MBAdobe PDFVisualizar/Abrir


Este ítem está sujeto a una licencia Creative Commons Licencia Creative Commons Creative Commons